Schering discloses new leukotriene antagonists particularly useful as dermatological products Feb. 3, 1999 No Comments
Promising results reported from pilot studies of MaxDerm in several skin conditions Jan. 12, 1999 No Comments
Xoma completes phase II development of hu1124; Genentech will decide future course Jan. 11, 1999 No Comments
RSS